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Purpose: The purpose of this study was to perform a preliminary histopathologic analysis 
ofexplanted human endovascular stented grafts from patients treated for occlusive disease. 
Methods: Over a 16-month period, 26 endovascular stented grafts were placed in 21 
patients with limb-threatening ischemia caused by aortoiliac or femoral artery occlusive 
disease. All grafts were inserted through open arteriotomies remote from the region of 
primary disease. During the follow-up period, two patients died of preexisting heart 
disease 2weeks and 7 months after grafting, and a portion of their endovascular g afts with 
the surrounding artery was explanted. Specimens from five other endovascular g afts were 
obtained uring surgical revision for graft stenosis after 3 and 6 weeks and for outflow 
artery stenosis after 3, 5, and 6 months. All specimens were formalin fixed and studied with 
hematoxylin and eosin and trichrome staining and immunohistochemically for factor 
VII I-related antigen, alpha actin smooth muscle, macrophage antigen (MAC-387) and 
PC-10 (a mouse monoclonal antibody which specifically recognizes proliferating cell 
nuclear antigen in paraffin sections). 
Results: Three weeks after placement of the stented grafts, organizing thrombus was 
present on both surfaces of the expanded polytetrafluoroethylene (PTFE) grafts. At 6 
weeks, evidence of a neointima with overlying endothelium was seen in the perianasto- 
motic region, and 3 months after graMng it was seen i to 3 cm from the anastomosis. The 
specimen explanted at 5 months demonstrated factor VIii-positive cells 8 cm from the 
anastomosis. The histopathologic condition of the external capsule appeared to vary, 
depending on the presence or absence of an external wrap on the PTFE graft and on which 
layer in the arterial wall the graft was inserted. A foreign body reaction characterized by 
multinucleated giant cells was seen adjacent to wrapped grafts or around those placed in 
an intraadventitial plane. Grafts inserted within the media were surrounded by orderly, 
arranged, smooth muscle cells and few mononudear cells. Extensive smooth muscle cell 
proliferation (PC-10 activity) was not seen within native artery atherosclerotic plaques 
peripherally displaced and external to prosthetic endovascular g afts. 
Conclusions: These preliminary observations on the healing ofPTFE endovascular stented 
grafts in human beings demonstrate limited plaque hyperplasia nd the presence of 
endothelial cells on the luminal surface remote from the graft-artery anastomosis. It  is 
unclear whether this is a unique manifestation of healing in prosthetic grafts inserted 
within the walls of arteries. (J VAsc SURG 1995;21:595-604.) 
From the Division of Vascular Surgery, Department ofSurgery, 
and the Division of Interventional Radiology, Department of
Radiology, Department of Radiology (Drs. Cynamon and 
Bakal), Montefiore Medical Center/Albert Einstein College of 
Medicine, New York, New York and the Department of 
Vascular Surgery (Dr. Parodi), Instituto Cardiovascular de
Buenos Aires, Buenos Aires, Argentina. 
Supported by grants from the U.S. Publilc Health Service (HL 
02990-01), the James Hilton Manning and Emma Austin 
Manning Foundation, The Anna S. Brown Trust, and the New 
York Institute for Vascular Studies. 
Presented atthe Eighth Annual Meeting of the Eastern Vascular 
Society, Montr&l, Quebec, Canada, May 12-15, 1994. 
Reprint requests: Michael L. Marin, MD, Division of Vascular 
Surgery, Montefiore Medical Center, 111 E. 210th St., New 
York, NY 10467. 
Copyright © 1995 by The Society for Vascular Surgery and 
International Society for Cardiovascular Surgery, North Ameri- 
can Chapter. 
0741-5214/95/$3.00 + 24/6/61749 
595 
JOURNAL OF VASCULAR SURGERY 
596 A/latin et al. April 1995 
Transluminally placed endovascular stented grafts 
(TPEGs) represent a blending of technologies by use 
of intravascular stents and prosthetic vascular grafts. 
TPEGs were first envisioned by Dotter 1in 1969 as 
intraluminal devices that would ultimately be useful 
for treating aneurysms, pseudoaneurysms, and arte- 
riovenous fistulas. With the development of new and 
creative intravascular stents, animal studies of TPEGs 
demonstrated the potential feasibility of these devices 
to treat arterial lesions. 24 Parodi et  al. s first demon- 
strated the clinical feasibility of stented grafts in the 
management of abdominal aortic aneurysms. Other 
applications of TPEGs to penetrating traumatic 
pseudoaneurysms and arteriovenous fistulas soon 
followed. 6,7 
TPEGs have also been used to treat arterial 
occlusive disease. This is accomplished byperforming 
long segment balloon angioplasty followed by inser- 
tion of the endovascular stented graft, sq° Mthough 
balloon angioplasty offocal stenoses has proven to be 
useful for treating isolated peripheral artery athero- 
sclerotic lesions, long segment disease or multiple, 
tandem stenoses treated by dilation alone have not 
displayed durable improvement,  Intravascular 
stents have played an important role in improving 
early and long-term patency in the iliac arteries, 
particularly after suboptimal angioplasty results. 
However, these devices have not proven to be 
effective with long segment disease. 12 It is precisely in 
these instances in which atherosclerotic disease in- 
volves a long segment of the vasculature that TPEGs 
may have their largest application. However, TPEGs 
have only recently been used for therapy in patients 
with such extensive disease, and their long-term 
follow-up has not as yet been demonstrated. 
It has been suggested that the patency of a 
prosthetic vascular conduit is determined, in part, 
by the healing properties of the graft. ~aa4 Incor- 
poration of the graft into surrounding tissues and 
the establishment of a stable neointima with the 
luminal surface of the conduit covered by functioning 
endothelium are believed to be important events 
for complete graft healing and optimal long-term 
function. 
Mthough much has been reported about the 
healing properties of commonly used prosthetic 
grafts in extraluminal locations, no such data are 
available concerning the arterial response to a pros- 
thetic graft placed within the lumen or wall of a 
human vessel. This report describes the histopatho- 
logic characteristics of TPEGs placed to treat limb- 
threatening ischemia caused by long segment arterial 
occlusive disease. 
METHODS 
Patients. Over a 16-month period 21 patients 
with angiographically proven, limb-threatening 
ischemia were treated with 26 endovascular stented 
grafts. All patients had one or more comorbid 
medical illnesses, causing them to be at high risk 
for standard vascular surgical repair of their oc- 
clusive disease. There were 20 aortoiliac-to-femoral 
and six femoral-to-popliteal grafts. A total of seven 
segments of endovascular grafts were recovered 
from seven patients. During the follow-up period, 
two patients died of heart failure unrelated to their 
TPEG procedure at 2 weeks and 7 months after 
endovascular grafting. A portion of the endovascular 
graft and surrounding artery was explanted uring 
an autopsy in these individuals. In five patients tent 
graft stenosis after 3 and 6 weeks and outflow artery 
stenosis after 3, 5, and 6 months necessitated 
surgical reintervention. Biopsies of grafts were 
obtained from the site of the new proximal anas- 
tomosis of the revised graft. All recovered grafts 
were patent when biopsied. The location of the 
biopsy in regard to the closest anastomosis was 
recorded for each graft. In each case, the endo- 
vascular graft and surrounding arterial wall were 
studied. 
TPEG technique. All endovascular stent graft 
procedures were performed in the operating room 
with fluoroscopic ontrol, and an arterial cutdown 
was performed in an access artery remote from the 
site of primary arterial disease (Fig. 1). Ideally, the 
rccanalization process i  started within the obstructed 
lumen of the vessel, but control of the route of 
recanalization is not possible. Recanalization of the 
superficial femoral artery (SFA) resulted in the wire 
emerging within the lumen of a patent popliteal 
artery. Balloon dilation of the newly created SFA 
tract was performed over the wire to a diameter of 6 
to 8 mm. Stent grafts were composed of 6 mm 
polytetrafluoroethylene (PTFE) grafts, some of 
which were devoid of an external wrap (Table I). A 
Palmaz balloon-expandable st nt (P294; Johnson 
and Johnson Interventional Systems, Warren, N.J.) 
was sutured to each graft with four CV-6 Gorc-tex 
sutures ~placed opposite ach other at both ends of 
the stent. A 50% overlap of stcnt and graft was used 
in all cases. This completed endovascular g aft was 
inserted over a wire to reline the newly formed ilated 
tract. 
Tissue processing and immunohistochemistry. 
With appropriate consent from the patients' families, 
~Gore-tex is a trademark of W.L. Gore & Associates, Elkton, Md. 
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Fig. 1. Schematic drawing of technique of endovascular stent graft repair for femoropopliteal 
occlusive disease. A, Guiding catheter (arrow) is inserted directly into SFA (0 represents occluded 
SFA). B, Angled directional catheters are usedto guide hydrophilic wire through occluded 
artery into patent popliteal vessel (arrow). Ideally, wire will travel within residual lumen of 
stenotic artery, or within intraintimal plane of occluded vessel (x). C, Diffuse balloon dilation 
with over-the-wire technique provides wi  tract for insertion of endovascular graft. D, Stent 
grafts are inserted and deployed at precise location, which is determined by fluoroscopic 
imaging. Retraction of guiding sheath exposes stent (arrow). E, Cranial end of graft may then 
be directly sewn tocommon femoral artery (A) or endoluminally anastomosed to inflow artery 
(B). Arteriotomy is then closed in continuous fashion over endoluminal nastomosis. 
two grafts were explanted at the time of postmortem 
and fixed in 10% neutral buffered formalin. The 
remNning five specimens in this study were obtained 
during surgery for correction of failing grafts. Ex- 
planted endovascular g afts were immediately fixed 
and embedded in paraffin. Sections were subse- 
quently stained immunohistochemically with anti- 
bodies to PC-10 (Dako, Santa Barbara, Calif.) (a 
mouse monoclonal antibody that specifically recog- 
nizes proliferating cell nuclear antigen in paraffin 
sections), alpha smooth muscle actin, macrophage 
antigen (MAC-387; Dako), Ulex-Europeaus (Dako) 
and factor VIII-related antigen. PC-10 was used at a 
dilution of 1 : 150 with overnight incubation accord- 
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Table I. Histopathologc characterization f transluminally placed endovascular stented grafts 
Native artery 
External plaque 
A/los. Location Luminal graft Intragraft proliferation 
Bypass after sampled]- Tissue Graft Intramural histologic histologic histologic (PC-10 
Graft ~ procedure grafting (cm) source type~: location condition§ conditionJl condition¶ staining)# 
a Femoropop- 0.5 1 Postmortem B Intraintimal ] 1 A + 
liteal 
b Femoropop- 0.5 4 Postmortem B Intraintimal 1 1 A + 
liteal 
c Femoropop- 0.5 8 Postmortem B Intramedial 1 1 A + 
liteal 
d Femoropop- 0.5 16 Postmortem B Intraadventitial 1 1 A + 
liteal 
e Femoropop- 0.5 20 Postmortem B Intramedial 1 1 A + 
liteal 
a Femoropop- 7 I Postmortem B Intraintimal 3 3 A + 
liteal 
b Femoropop- 7 2 Postmortem B Intraintimal 2 3 A + 
fiteal 
c Femoropop- 7 4 Postmortem B Intramedial 3 3 B + + 
ljteal 
d Femoropop- 7 6 Postmortem B Intramedial 2 3 A + 
liteal 
e Femoropop- 7 8 Postmortem B Intraadventitial 2 2 A + 
liteal 
Aortofemoral 0.75 2 Surgical revision A Intraintimal 1 2 A + 
Aortofemoral 5 8 Surgical revision A Intramedial 3 2 A + + + 
Aortofemoral 1.5 2 Surgical revision B Intraintimal 3 3 A + 
a Iliofemoral 6 1 Surgical revision B Intraintimal 2 3 B + 
b Iliofemoral 6 2 Surgical revision B Intraintimal 2 3 C + 
c Iliofemoral 6 4 Surgical revision B Intraintimal 2 2 B + 
a Aortofemoral 3 1 Surgical revision A Intraintimal 2 2 A + 
b Aortofemoral 3 2 Surgical revision A Intraintimal 3 2 A + 
c Aortofemoral 3 3 Surgical revision A Intraintimal 2 2 A + 
~Numbers are individual grafts; letters are unique segments of each graft. 
~Centimeters f om proximal stent anastomosis (aortoiliac bypass) or distal stent anastomosis (femoropopliteal bypass). 
~:A represents Gore-rex with external coating, B represents Gore-rex without external coating. 
§1 represents compacted fibrin and organizing thrombus; 2 represents neointima (smooth muscle cells without overlying endothelium; 
3 represents neointimal smooth muscle cells with overlying endothelium. 
II1 represents organizing thrombus; 2 represents foreign body/macrophage reaction; 3 represents organized smooth muscle cells. 
~A represents mononucleated cell matrix; B represents occasional capillaries and fibroblasts; C represents extensive capillary formation. 
#At original magnification x 40, + represents occasional positive cells; + + represents four to five positive cells; + + + represents greater 
than 5 positive cells. 
ing to the procedure described by Hal l  et al. is 
Sections o f  l ymph node  germinal  centers served as 
posit ive controls.  MAC-387 in a d i lu t ion  o f  1 : 50 was 
used to label macrophages in the perigraft tissues, 
w i th  spleen tissue as a posit ive control .  Rabb i t  
polyclonal  factor V I I I - re la ted  ant igen (1 :1000)  
and/or  U lex-Europeaus type 1 (5 i , l /ml) and type 2 
(1 :200)  (Dako) were used to identify endothel ia l  
cells. 
V isual izat ion was per formed wi th  the avidin- 
b iot in  complex and peroxidase (Dako).  
RESULTS 
Three weeks after insert ion o f  the TPEGs ,  the 
graft tissue specimens were encased on  both  the 
internal  and the external surfaces by organiz ing 
thrombus ,  which  was adherent  to the PTFE  material. 
Mononuc lear  cell inf i l trat ion wi th  neovascular izat ion 
o f  the thrombus  was readily apparent.  Endovascular  
graft specimens examined at 6 weeks showed firm 
at tachment  o f  the native arterial wall  to the external 
surface o f  the graft. The lumina l  surface o f  the graft 
was covered by a neo in t ima composed o f  a thin,  
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Fig. 2. (A) Light micrograph of endovascular ortofemoral PTFE graft (q) studied 6 weeks 
after insertion. Neointima composed of monolayer of cells overlying thin fibrous troma covers 
graft at site 2 cm from distal anastomosis (arrow) (L represents lumen). (Ttichrome stain.) (B) 
Immunohistochemical staining for factor VIII-related antigen labels cell monolayer positive 
(arrow) (L represents lumen). 
fibrous tissue base and an overlying cell monolayer 
(Fig. 2, A). This single layer of attenuated cells 
stained positive for factor VIII-related antigens in 
6-week-old specimens harvested 2 cm from the 
endovascular graft-to-artery anastomosis (Fig. 2, B). 
At 3 months the neointima was noted to be well 
developed and measured between 40 and 150 ~xm 
thick in specimens obtained from areas 1 to 3 cm 
from the anastomosis. In specimens examined be- 
tween 3 and 7 months, the external surface of the 
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Fig. 3. (A) Macroscopic longitudinal image of perianastomotic region of aortofemoral 
endovascular stented graft studied 3 months after grafting. Note stenosis at artery-to-graft 
interface (open arrow). (Solid arrows represent endoluminal nastomotic sutures.) (B) Neointimal 
hyperplastic smooth muscle cell response (N) is seen 1 cm from anastomosis (G represents graft; 
arrow points toward lumen). (Hematoxylin and eosin staining.). 
graft was well incorporated, with some variation in 
the histologic omposition of the external capsule of 
the graft (Table I). Those grafts that contained an 
external wrap or were placed within a periadventitial 
plane of the native artery developed a foreign body 
reaction characterized by a well-defined layer of 
multinucleated giant cells and mononuclear cells that 
were positive for MAC-387. The grafts that were 
inserted into the media of the artery displayed a less 
prominent mononuclear nd giant cell reaction, with 
orderly, arranged anti-alpha smooth muscle positive 
cells surrounding the external graft surface. Regard- 
less of the perigraft cellular composition, few capil- 
laries were seen traversing thc prosthetic graft wall 
towards the lumen. 
In one failing graft specimen that was explanted 
3 months after grafting, a stenosis was found at the 
distal graft-to-artery endoluminal sewn anastomosis. 
This graft demonstrated marked neointimal thicken- 
ing over the distal 15 mm graft segment (Fig. 3). A 
smooth muscle cell hyperplastic response was present 
within the neointima (Fig. 3, B). 
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Fig. 4. Light micrograph ofendovascular stented graft within external iliac artery explanted at 
6 months. Most of the displaced native vessel plaque (P) is composed of fibrous tissue. Cellularity 
is seen in region of obliterated native lumen (arrow). Inset, PC-10 immunoreactivity is 
documented predominantly in region denoted by arrowin main figure (arrows represent 
PC-10-positive nuclei). 
The fate of compressed atherosclerotic plaque 
external to TPEGs was evaluated for cellular prolif- 
eration with antibody labeling for PC-10. All plaque 
tissues contained in the iliac and common femoral 
arteries and SFA external to the stented grafts were 
predominantly composed of acellular fibrous tissue 
with frequent mineralization (Fig. 4). Regions of 
cellularity were occasionally seen within the obliter- 
ated native arterial umen. Minimal PC-10 labeling 
was frequently seen in these regions. 
In one graft segment, extrinsic graft smooth 
muscle cell proliferation was detected, which ap- 
peared to indent the graft. This lesion had not been 
associated with a hemodynamically significant steno- 
sis on duplex ultrasonography or angiography. 
DISCUSSION 
TPEGs represent a new concept in vascular 
surgery, integrating the principles of standard pros- 
thetic grafting with endovascular techniques. Al- 
though it is commonly accepted that endoluminal 
procedures such as percutaneous balloon angloplasty 
are effective therapies for focal arterial stenoses, uch 
endovascular treatments are usually inadequate when 
the disease involves long segments of the vasculature 
in excess of 5 cm. 11 However, TPEGs allow for the 
insertion of a new lining to cover diffusely dilated 
arteries, excluding the arteriosclerotic plaque, dissec- 
tions, and flaps from the circulation. Although 
preliminary experiences with stented grafts have been 
encouraging, .there are little data regarding host 
arterial responses and healing. 
Work in experimental nimals has shown that 
healing will occur in endovascular g afts inserted to 
treat experimentally created arterial aneurysms. 4,s
Neointimal thickening at the interface between the 
stent and the arterial wall is believed to promote firm 
stent graft attachment. Although this arterial re- 
sponse is acceptable and even desirable for large- 
vessel endovascular grafts, the same response in a 
small atherosclerotic vessel may result in an endovas- 
cular graft stenosis and failure. In addition, the 
precise response of a diseased arterial wall to an 
endovascular p ocedure may be different in normal 
animal vessels compared with human aneurysmal 
arteries,  Finally, although certain animals may dem- 
onstrate unique capabilities to heal and endothelialize 
prosthetic grafts placed in extraluminal nd endolu- 
minal positions, similar results have yet to be 
documented in human beings. 16,17 
This study analyzes a limited number of patho- 
logic specimens obtained at postmortem examination 
or at the time of surgical correction of failing 
endovascular g afts. Although the data are limited, 
these observations demonstrate a preliminary under- 
standing of the healing characteristics of these 
endovascular grafts. Two grafts demonstrated evi- 
dence of endothelialization at sites 2 to 8 cm from the 
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graft-to-artery interface. This unusual finding may be 
related to the proximity of the partially porous graft 
to the underlying arterial wall. The presence of 
arterial wall cells in close apposition to the external 
graft surface could mediate local events necessary for 
endothelial migration or proliferation. The impor- 
tance of chemical mediators for regulating local 
arterial wall responses is well established. 18 Cocul- 
nares of vascular wall endothelial and smooth muscle 
cells have only recently begun to define the important 
relationship between these two specialized cells, and 
the interactive biologic actiyity of these cells on each 
other may be essential for maximal functional graft 
healing. 19 
The external capsule of endovascular grafts dem- 
onstrated considerable histologic variability, which 
ranged from marked mononuclear and multinu- 
clear foreign body reactions to little or no arterial 
wall mononuclear esponse with orderly, arranged 
smooth muscle cells surrounding the graft. The data 
in this study suggest hat the foreign body response 
was more prevalent in PTFE grafts that contained an 
external wrap or were inserted into the periadventitial 
space. Recanalization occurs in a somewhat random 
fashion, with the angiographic wire following along 
planes of least resistance. This event permitted the 
composition of the external capsule to vary within 
different segments of the same endovascular graft 
depending on which layer of the arterial wall the 
randomly created dissecting tract placed the endo- 
vascular graft. Although no data were obtained in this 
study to support the contention that long-term 
endovascular graft function may be improved by a 
specific mural location, the presence of significant 
macrophage infiltration in perigraft tissue has been 
shown by others to have an adverse ffect on standard 
extravascnlar graft healing. 2°,21 Extensive macro- 
phage infiltration with giant cell reaction after the 
implantation of prosthetic grafts is associated with 
the release of cell growth regulating substances (basic 
fibroblast growth factor, transforming rowth factor 
13), which may, in part, control junctional neointimal 
formation. 
Endovascular stented grafts represent a new 
technique for treating extensive atherosclerotic oc- 
clusive vascular disease. This preliminary histopatho- 
logic investigation identified several unique features 
of endovascular graft healing, which may result in a 
functional advantage of these prosthetic vascular 
conduits. Although enhanced graft healing may be 
possible with this technique, the problems of neoin- 
timal hyperplasia and progression of atherosclerotic 
disease in outflow vessels will continue to be impor- 
tant potential sources of graft failure. 
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DISCUSSION 
Dr. Richard F. Neville (Washington, D.C.). It is a 
privilege to discuss this important study from a leading 
group in the development of endovascular g afting. Dr. 
Marin reports on a subset of the Montefiore experience 
with use of 6 mm PTFE grafts and Palmaz stents to 
deploy 26 endovascular grafts in 21 patients with aor- 
toiliac and femoropopliteal occlusive disease. Then, be- 
cause of death or additional operative procedures, Dr. 
Matin had the opportunity to harvest segments of 
seven grafts. The graft segments, which were explanted 
from 2 weeks to 7 months after implantation, were 
studied histologically. Endovascular grafting continues 
to generate many interesting clinical questions and 
concerns; however, the thrust of this study is clearly the 
histologic healing response to endovascular g aft implan- 
tation. 
My first question concerns the grafts harvested uring 
operative procedures for revision of stenoses that devel- 
oped during follow-up. Stent work in animal models and 
the coronary circulation indicates that stenosis occurs at the 
junction between the native artery and the stent. Were you 
able to determine the location of the stenosis that occurs in 
endovascular g afts? Does stenosis occur at the artery-graft 
interface, in the stent itself, or the body of the graft? Were 
you able to characterize your early stenoses as caused by 
thrombus, incomplete stent expansion, or myointimal 
hyperplasia? Do you think this is a process imilar to that 
which plagues tandard bypass grafts? 
The second issue concerns neointimal coverage of the 
endovascular g aft and stent struts. Yon noticed neointimal 
coverage 6 weeks after deployment. Was there a pattern to 
the neointimal coverage in terms of the time from 
deployment or location in the graft? In animal studies we 
have noted that stent coverage by neointima begins at 3 
weeks, is not complete for approximately 8 weeks, and 
seems to be dependent on contact between the stent struts 
and the arterial intima. Were stent struts located in the body 
of the prosthetic graft remote from the interface with the 
native artery covered by neointima nd was there differen- 
tial coverage between the stent and graft surfaces? Should 
patients be given an anticoagulant for several weeks until 
this neointimal coverage occurs? 
We have also noticed in animal work the importance of 
complete contact with the arterial wall after stent deploy- 
ment to enhance not only neointimal coverage but also to 
decrease complications such as migration and thrombosis. 
Intravascular ultrasonography is an accurate method to 
assess tent deployment. Are you considering the use of 
intravascular ultrasonography to assess graft expansion and 
contact with the arterial wall. 
It is hoped that investigations uch as this will 
eventually lead to favorable manipulation of the arterial 
wall response, which is critical for the true success of 
endovascular therapy. I have no doubt that rapidly 
advancing technology will overcome the problems of 
device deployment for both occlusive and aneurysmal 
disease. Endovascular device deployment must also con- 
tinue to be spearheaded byvascular surgeons who maintain 
careful follow-up of their patients and analyze their results 
beyond the immediate treatment period. 
Dr. Michael Matin. The location of stenoses within 
stent grafts can frequently be difficult to detect. However, 
the best method for identifying these lesions is the use of 
arteriography or duplex scanning. We had only two stent 
graft stenoses. In one, we saw apparent hyperplasia within 
the stent hat may have been caused by inadequate dilation 
of the stent at the time of the primary procedure. We can 
anticipate from some of Dr. Parodi's experimental work 
that at least I to 2 mm of hyperplastic pannus will develop 
around the endovascular stent. Therefore, if grafts are 
dilated only to 6 mm and 2 mm narrowing develops, there 
will be significant overall narrowing of the graft lumen. We 
now dilate to 8 mm, and this problem has not been seen. 
The second main area of stent graft stenosis that was seen 
in the analysis of our entire series was within the outflow 
arteries. Unfortunately, endovascular grafting will not 
affect he progression of disease in these vessels. This point 
emphasizes the need for continued surveillance of grafts 
after surgery for potential stenoses. 
You mentioned the importance of contact of the stent 
to the arterial wall. This is very important and was 
recognized some time ago by Palmaz in experimental 
experience with his stent (Palmaz JC, et al. Radiology 
1987;164:705-8). We believe that the absence of good 
contact to the arterial wall is the primary reason that 
multiple stents for long segment disease will not be 
effective. As an example, we had a patient with a 
long-segment lilac artery stenosis that was treated by 
insertion of a series of Palmaz stents (a total of seven). 
Unfortunately, this patient had thrombosis of this re- 
construction and subsequently died. An autopsy was 
performed, and the aortoiliac segment was harvested with 
the contained stents. On opening the vessel in the 
diffusely dilated and dissected artery, there was poor 
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contact of the endovascular stent o the underlying arterial 
wall. This allowed for accumulation of thrombus under 
the stent, and failure occurred, as might be expected. 
We have not used long-term anticoagulation i  our 
patients. They are given an anticoagulant only at the time 
of the procedure, unless there is a medical reason for 
long-term anticoagulation. 
Finally, you make an excellent point about he potential 
importance of intraluminal ultrasonography in these pro- 
cedures. Clear-cut determinations ofstent apposition to the 
arterial wall can be made. Twists in grafts and extrinsic 
stenosis can be identified. Therefore, yes, I believe that 
intraluminal nltrasonography is important and should be 
part of all projects. 
Dr. Keith D. Calligaro (Philadelphia, Pa.). Do you 
have any evidence from your group or from any other 
group that this technology is better than a simple balloon 
angioplasty? I realize that you are presenting preliminary 
data, but some type of comparative studies are going to 
have to be made. Just as lasers have not really worked out 
well in the peripheral vascular system, this technique may 
also not be better than simple balloon angioplasty. 
Dr. Michael Matin. As with every new technology 
that comes along, someone always states that we need a 
randomized, prospective, double-blind placebo controlled 
trial. We do need a carefully controlled trial comparing 
conventional surgery, balloon angioplasty, intravascular 
stents, and stented grafts. 
Dr. Juan Parodi. We have just completed a study in 
dogs in which we performed balloon angioplasty in both 
iliac arteries and covered one iliac artery with a PTFE stent 
graft and left the other iliac artery bare. We found little 
reaction in the tissue with no intimal hyperplasia in those 
vessels covered by the PTFE stent grafts. Another inter- 
esting finding was the identification 0fhyperplasia through 
a graft that had been inadvertently fenestrated uring 
insertion. We saw hyperplasia only at that site, and the rest 
of the area covered with PTFE was normal. 
Dr. Luis Queral (Baltimore, Md.). Our experience 
with mukiple stents in either the superficial femoral or iliac 
artery segment has been terrible. When you have extensive 
external i iac or femoral artery disease, the way to go is a 
bypass. Do you place the bypass inside or outside the 
artery? 
Dr. Harry L. Bush, Jr. (New York, N.Y.). Your 
current observations of intimal hyperplasia t the distal 
anastomosis and, presumably in the future, at the proximal 
anastomosis will need further analysis. I am intrigued by 
the observation that you do not see more disease in the mid 
portion of the grafts. Specifically, the failure rate for 
long-segment angioplasty at the external i iac or superficial 
femoral artery level is usually related to the recoil of the 
plaque or rapid recurrence of intimal hyperplasia. Can you 
speculate as to why you are seeing none of that in your 
cases? Is it because your grafts are ending up in the 
subadventitial layer as opposed to going within the mid 
portion of a dilated plaque? The question that troubles 
some of us is that I gather it is becoming increasingly 
difficult from a legal standpoint o use hybrid grafts 
composed of approved stents and prosthetic grafts. How 
did you approach this in terms of use of this kind of material 
on a clinical level? 
Dr. Matin. Your first question is one that we raised 
almost 2 years ago when we first conceptualized these 
procedures with Dr. Parodi. What we found from fresh 
cadaver vessel analysis was that if you perform minimal 
dilation of an occluded or stenotic artery, recoil can be very 
significant. However, if you perform diffuse dilation, and 
I use the term "dilation" not "angioplasty," recoil is not a 
concern. 
You raised the question concerning in which layer of 
the artery does the graft reside. Lack of recoil may, in part, 
be caused by placement of grafts within the adventitia, as 
you have noted. However, some are clearly in an intrain- 
timal plane without recoil being seen. In answer to your 
question about hybrid grafts, we continue to use devices 
created from Food and Drug Administration-approved 
material. We use standard 6 mm PTFE and iliac artery 
stents. A combination of these materials appears to be the 
best approach for treatment of the subset of patients who 
have received these grafts. 
Dr. Jack L. Cronenwett (Lebanon, N.H.). I was 
intrigued by your observation that you see factor VII- 
I-positive cells some distance from the distal end of these 
grafts, which is a variance from the experience with 
surgically implanted PTFE grafts. Can you tell how 
homogeneous these cells are by surface scanning with 
electron microscopy? Do you really believe that these grafts 
will become endothelialized, and, if so, why are they 
different from grafts placed in a more standard fashion? 
Dr. Matin. Your question touches on what is perhaps 
the most important issue regarding healing ofendovascular 
grafts. We have not been successful in electron microscopy 
analysis of our specimens. I have made several unsuccessful 
attempts to detect an endothelial cell monolayer. I think 
our problem with electron microscopy has been technical, 
because the cells on the graft surface seem to be loosely 
adherent to the graft and appear to wash off during critical 
point drying, dehydration, and coating of the specimens. 
We have analyzed two specimens with scanning electron 
microscopy, and the only thing we have seen is occasional 
groupings of cells that were questionable with regard to 
whether they were endothelium. 
The reason that endovascular g afts develop an endo- 
thelium compared with extraluminal grafts is unknown, 
but it may be related to the effects of surrounding cells. 
Your group has identified the importance of endothelial 
cell-smooth muscle cell interactions in cocultures and the 
effect of these reactions on the evolution of a stable intima. 
A close association of vascular wall cells may be essential to 
ideal prosthetic graft healing. What has to be factored into 
future devices is how thick the graft needs to be and how 
porous it should be to permit transgraft migration and 
diffusion. 
